AVITA Medical, Inc. (RCEL) stock
RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
$15.77+0.55 (+3.61%)
Close on Nov 17, 2026Market cap $487.72MP/E –Yield –
AVITA Medical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
AVITA Medical's operating income for the twelve months ending Jun 30, 2026 was -$35.22M. For fiscal 2025 it was -$42.53M. The highest annual figure on record is -$13.84M in fiscal 2018.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$42.53M | – |
| FY2024 | Dec 31, 2024 | -$56.59M | – |
| FY2023 | Dec 31, 2023 | -$42.66M | – |
| FY2021 | Jun 30, 2021 | -$26.54M | – |
| FY2020 | Jun 30, 2020 | -$42.68M | – |
| FY2019 | Jun 30, 2019 | -$25.53M | – |
| FY2018 | Jun 30, 2018 | -$13.84M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$6.86M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$8.80M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$10.41M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$9.15M | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$11.15M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$11.83M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$9.96M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$13.81M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$15.62M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$17.21M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$12.27M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$9.31M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$11.17M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$9.91M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$4.70M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$5.99M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$5.63M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$10.21M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$13.02M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$15.41M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$10.59M | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$3.66M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$7.49M | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$6.68M | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$6.30M | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$5.06M | – |
See a number that looks wrong?